QQQ $ 592.25 $ 0.00 (0 %)
DIA $ 455.81 $ 0.00 (0 %)
SPY $ 653.61 $ 0.00 (0 %)
TLT $ 91.58 $ 0.00 (0 %)
GLD $ 399.09 $ 0.00 (0 %)
$ 20.01
-- x --
-- x --
-- - --
$ 5.34 - $ 23.41
7,916
na
50.26M
$ 2.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2024 09-30-2024 10-Q
2 08-13-2024 06-30-2024 10-Q
3 05-14-2024 03-31-2024 10-Q
4 03-18-2024 12-31-2023 10-K
5 11-14-2023 09-30-2023 10-Q
6 08-09-2023 06-30-2023 10-Q
7 05-09-2023 03-31-2023 10-Q
8 03-02-2023 12-31-2022 10-K
9 11-07-2022 09-30-2022 10-Q
10 08-09-2022 06-30-2022 10-Q
11 05-10-2022 03-31-2022 10-Q
12 03-14-2022 12-31-2021 10-K
13 11-09-2021 09-30-2021 10-Q
14 08-03-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 singular-genomics-enters-into-agreement-to-be-acquired-by-deerfield-for-20-in-cash-per-share

Singular Genomics Systems, Inc. (NASDAQ:OMIC) ("Singular Genomics" or the "Company"), a company leveraging nove...

 singular-genomics-sys-q3-eps-672-beats-786-estimate-sales-40600k-miss-82500k-estimate

Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(6.72) per share which beat the analyst consensus estimate of...

 singular-genomics-receives-non-binding-acquisition-proposal-from-concentra-biosciences-and-tang-capital-to-acquire-all-of-the-companys-outstanding-shares-of-common-stock-for-1200-per-share-in-cash

Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomi...

 whats-going-on-with-singular-genomics-stock-friday

Singular Genomics shares are trading higher Friday after the company announced it received a non-binding acquisition proposal f...

 singular-genomics-sys-q2-2024-gaap-eps-857-beats-895-estimate-sales-73700k-beat-40000k-estimate

Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(8.57) per share which beat the analyst consensus estimate of...

 goldman-sachs-maintains-neutral-on-singular-genomics-sys-lowers-price-target-to-65

Goldman Sachs analyst Matthew Sykes maintains Singular Genomics Sys (NASDAQ:OMIC) with a Neutral and lowers the price target...

 goldman-sachs-maintains-neutral-on-singular-genomics-sys-lowers-price-target-to-075

Goldman Sachs analyst Matthew Sykes maintains Singular Genomics Sys (NASDAQ:OMIC) with a Neutral and lowers the price target...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION